Euglycemic Diabetic Ketoacidosis - Can You Identify & Treat This Novel Syndrome? 

By: Christopher G. Byers, DVM, DACVECC, DACVIM (SAIM), CVJ

Description: In recent months, sodium-glucose co-transporter 2 inhibitors (SGLT2i) have become available for the treatment of insulin-dependent diabetes mellitus in feline patients. One of the rare potential side effects of this class of medication is euglycemic diabetic ketoacidosis (eDKA). Learners will review relevant pathophysiology of, as well as diagnostic testing and therapeutic interventions for cats suspected or confirmed to be living with eDKA.

By the end of the session, attendees will be able to:

1. To understand the mechanism of action of sodium-glucose co-transporter 2 inhibitors
2. To recognize clinical manifestations of euglycemic diabetic ketoacidosis in cats
3. To understand appropriate diagnostic tests to accurately diagnose patients living with eDKA
4. To having working knowledge of appropriate therapeutic interventions for eDKA

Speaker Info: Dr. Christopher G. Byers is a board-certified veterinary emergency & critical care and small animal internal medicine specialist, as well as a certified veterinary journalist, based in Omaha, Nebraska. He received his DDVM from Cornell University. Dr. Byers works as a teleconsultant in for VetCT, and he is the Co-Editor of the textbooks, Feline Emergency & Critical Care Medicine and Canine Emergency & Critical Care Medicine. He has also published chapters and articles in numerous textbooks and peer-reviewed medical journals.